In vitro and in vivo anti-primary effusion lymphoma activities of fucoidan extracted from Cladosiphon okamuranus Tokida

Ishikawa,Chie; Mori,Naoki

doi:10.3892/or.2017.5978

In vitro and in vivo anti-primary effusion lymphoma activities of fucoidan extracted from Cladosiphon okamuranus Tokida

Authors:
- Chie Ishikawa
- Naoki Mori
View Affiliations

Affiliations: Department of Microbiology and Oncology, Graduate School of Medicine, University of the Ryukyus, Nishihara, Okinawa 903-0215, Japan
Published online on: September 20, 2017 https://doi.org/10.3892/or.2017.5978
Pages: 3197-3204

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Primary effusion lymphoma (PEL) caused by Kaposi's sarcoma-associated herpesvirus (KSHV) is characterized by lymphomatous effusion in body cavities and poor prognosis. There is still no effective treatment for PEL. Fucoidan, a major sulfated polysaccharide isolated from brown seaweeds, has an attractive array of bioactivities such as cancer inhibition. However, the effects of fucoidan on PEL cells remain unclear. We investigated the anti-PEL effects of fucoidan obtained from Cladosiphon okamuranus Tokida cultivated in Okinawa. Fucoidan dose-dependently inhibited the proliferation of KSHV-infected PEL cell lines, and provoked G1 cell cycle arrest, which was accompanied by CDK4 and CDK6 downregulation. Fucoidan also induced apoptosis of PEL cells through caspase-3, -8 and -9 activation; this occurred partly through the downregulation of anti-apoptotic Bcl-xL, Mcl-1 and XIAP proteins. Fucoidan also suppressed nuclear factor-κB, activator protein-1 (AP-1), and T-lymphokine-activated killer cell-originated protein kinase (TOPK) signaling pathways through inhibition of phosphorylation of IκBα and TOPK, and the expression of AP-1 family proteins, JunB and JunD. Oral administration of fucoidan effectively inhibited the development of PEL cells and ascites in a xenograft SCID mouse model, with minimal serious adverse effects. Notably, native fucoidan exhibited a more efficient anti-PEL effect than nanoparticle fucoidan. These preclinical findings highlight the anti-PEL actions of fucoidan, suggesting it could be potentially useful for the prevention and treatment of PEL.

View Figures

View References

1	Okada S, Goto H and Yotsumoto M: Current status of treatment for primary effusion lymphoma. Intractable Rare Dis Res. 3:65–74. 2014. View Article : Google Scholar : PubMed/NCBI
2	Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Sald J and Knowles DM: Primary effusion lymphoma: A distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood. 88:645–656. 1996.PubMed/NCBI
3	Chen YB, Rahemtullah A and Hochberg E: Primary effusion lymphoma. Oncologist. 12:569–576. 2007. View Article : Google Scholar : PubMed/NCBI
4	Carbone A and Gloghini A: KSHV/HHV8-associated lymphomas. Br J Haematol. 140:13–24. 2008.PubMed/NCBI
5	Keller SA, Schattner EJ and Cesarman E: Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood. 96:2537–2542. 2000.PubMed/NCBI
6	Gopalakrishnan R, Matta H and Chaudhary PM: A purine scaffold HSP90 inhibitor BIIB021 has selective activity against KSHV-associated primary effusion lymphoma and blocks vFLIP K13-induced NF-κB. Clin Cancer Res. 19:5016–5026. 2013. View Article : Google Scholar : PubMed/NCBI
7	Cannon ML and Cesarman E: The KSHV G protein-coupled receptor signals via multiple pathways to induce transcription factor activation in primary effusion lymphoma cells. Oncogene. 23:514–523. 2004. View Article : Google Scholar : PubMed/NCBI
8	An J, Sun Y, Sun R and Rettig MB: Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: The role of the NF-kappaB and JNK/AP1 pathways. Oncogene. 22:3371–3385. 2003. View Article : Google Scholar : PubMed/NCBI
9	Kwak J-Y: Fucoidan as a marine anticancer agent in preclinical development. Mar Drugs. 12:851–870. 2014. View Article : Google Scholar : PubMed/NCBI
10	Wang W, Wang S-X and Guan H-S: The antiviral activities and mechanisms of marine polysaccharides: An overview. Mar Drugs. 10:2795–2816. 2012. View Article : Google Scholar : PubMed/NCBI
11	Mori N, Nakasone K, Tomimori K and Ishikawa C: Beneficial effects of fucoidan in patients with chronic hepatitis C virus infection. World J Gastroenterol. 18:2225–2230. 2012. View Article : Google Scholar : PubMed/NCBI
12	Araya N, Takahashi K, Sato T, Nakamura T, Sawa C, Hasegawa D, Ando H, Aratani S, Yagishita N, Fujii R, et al: Fucoidan therapy decreases the proviral load in patients with human T-lymphotropic virus type-1-associated neurological disease. Antivir Ther. 16:89–98. 2011. View Article : Google Scholar : PubMed/NCBI
13	Takeda K, Tomimori K, Kimura R, Ishikawa C, Nowling TK and Mori N: Anti-tumor activity of fucoidan is mediated by nitric oxide released from macrophages. Int J Oncol. 40:251–260. 2012.PubMed/NCBI
14	Kimura R, Rokkaku T, Takeda S, Senba M and Mori N: Cytotoxic effects of fucoidan nanoparticles against osteosarcoma. Mar Drugs. 11:4267–4278. 2013. View Article : Google Scholar : PubMed/NCBI
15	Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D and Ganem D: Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med. 2:342–346. 1996. View Article : Google Scholar : PubMed/NCBI
16	Katano H, Hoshino Y, Morishita Y, Nakamura T, Satoh H, Iwamoto A, Herndier B and Mori S: Establishing and characterizing a CD30-positive cell line harboring HHV-8 from a primary effusion lymphoma. J Med Virol. 58:394–401. 1999. View Article : Google Scholar : PubMed/NCBI
17	Mori N and Prager D: Transactivation of the interleukin-1alpha promoter by human T-cell leukemia virus type I and type II Tax proteins. Blood. 87:3410–3417. 1996.PubMed/NCBI
18	Zhang C, Ao Z, Seth A and Schlossman SF: A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells. J Immunol. 157:3980–3987. 1996.PubMed/NCBI
19	Khan N, Afaq F and Mukhtar H: Apoptosis by dietary factors: The suicide solution for delaying cancer growth. Carcinogenesis. 28:233–239. 2007. View Article : Google Scholar : PubMed/NCBI
20	Hayden MS and Ghosh S: Shared principles in NF-kappaB signaling. Cell. 132:344–362. 2008. View Article : Google Scholar : PubMed/NCBI
21	Simons-Evelyn M, Bailey-Dell K, Toretsky JA, Ross DD, Fenton R, Kalvakolanu D and Rapoport AP: PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cells. Blood Cells Mol Dis. 27:825–829. 2001. View Article : Google Scholar : PubMed/NCBI
22	Abe Y, Takeuchi T, Kagawa-Miki L, Ueda N, Shigemoto K, Yasukawa M and Kito K: A mitotic kinase TOPK enhances Cdk1/cyclin B1-dependent phosphorylation of PRC1 and promotes cytokinesis. J Mol Biol. 370:231–245. 2007. View Article : Google Scholar : PubMed/NCBI
23	Vishchuk OS, Sun H, Wang Z, Ermakova SP, Xiao J, Lu T, Xue P, Zvyagintseva TN, Xiong H, Shao C, et al: PDZ-binding kinase/T-LAK cell-originated protein kinase is a target of the fucoidan from brown alga Fucus evanescens in the prevention of EGF-induced neoplastic cell transformation and colon cancer growth. Oncotarget. 7:18763–18773. 2016. View Article : Google Scholar : PubMed/NCBI
24	Park J-H, Yoon D-S, Choi H-J, Hahm D-H and Oh S-M: Phosphorylation of IκBα at serine 32 by T-lymphokine-activated killer cell-originated protein kinase is essential for chemoresistance against doxorubicin in cervical cancer cells. J Biol Chem. 288:3585–3593. 2013. View Article : Google Scholar : PubMed/NCBI
25	Michai M, Goto H, Hattori S, Vaeteewoottacharn K, Wongkham C, Wongkham S and Okada S: Soluble CD30: A possible serum tumor marker for primary effusion lymphoma. Asian Pac J Cancer Prev. 13:4939–4941. 2012. View Article : Google Scholar : PubMed/NCBI
26	Yang C, Chung D, Shin IS, Lee H, Kim J, Lee Y and You S: Effects of molecular weight and hydrolysis conditions on anticancer activity of fucoidans from sporophyll of Undaria pinnatifida. Int J Biol Macromol. 43:433–437. 2008. View Article : Google Scholar : PubMed/NCBI
27	Azuma K, Ishihara T, Nakamoto H, Amaha T, Osaki T, Tsuka T, Imagawa T, Minami S, Takashima O, Ifuku S, et al: Effects of oral administration of fucoidan extracted from Cladosiphon okamuranus on tumor growth and survival time in a tumor-bearing mouse model. Mar Drugs. 10:2337–2348. 2012. View Article : Google Scholar : PubMed/NCBI
28	Jiao G, Yu G, Zhang J and Ewart HS: Chemical structures and bioactivities of sulfated polysaccharides from marine algae. Mar Drugs. 9:196–223. 2011. View Article : Google Scholar : PubMed/NCBI
29	Haneji K, Matsuda T, Tomita M, Kawakami H, Ohshiro K, Uchihara JN, Masuda M, Takasu N, Tanaka Y, Ohta T, et al: Fucoidan extracted from Cladosiphon okamuranus Tokida induces apoptosis of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells. Nutr Cancer. 52:189–201. 2005. View Article : Google Scholar : PubMed/NCBI
30	Pahl HL: Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene. 18:6853–6866. 1999. View Article : Google Scholar : PubMed/NCBI
31	Iwanaga R, Ohtani K, Hayashi T and Nakamura M: Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I. Oncogene. 20:2055–2067. 2001. View Article : Google Scholar : PubMed/NCBI
32	Brown RT, Ades IZ and Nordan RP: An acute phase response factor/NF-kappa B site downstream of the junB gene that mediates responsiveness to interleukin-6 in a murine plasmacytoma. J Biol Chem. 270:31129–31135. 1995. View Article : Google Scholar : PubMed/NCBI
33	Li N, Zhang Q and Song J: Toxicological evaluation of fucoidan extracted from Laminaria japonica in Wistar rats. Food Chem Toxicol. 43:421–426. 2005. View Article : Google Scholar : PubMed/NCBI
34	Chung H-J, Jeun J, Houng S-J, Jun H-J, Kweon D-K and Lee S-J: Toxicological evaluation of fucoidan from Undaria pinnatifida in vitro and in vivo. Phytother Res. 24:1078–1083. 2010.PubMed/NCBI
35	Shimizu J, Wada-Funada U, Mano H, Matahira Y, Kawaguchi M and Wada M: Proportion of murine cytotoxic T cells is increased by high molecular-weight fucoidan extracted from Okinawa Mozuku (Cladosiphon okamuranus). J Health Sci. 51:394–397. 2005. View Article : Google Scholar
36	Bosma GC, Custer RP and Bosma MJ: A severe combined immunodeficiency mutation in the mouse. Nature. 301:527–530. 1983. View Article : Google Scholar : PubMed/NCBI
37	Dewan MZ, Terunuma H, Toi M, Tanaka Y, Katano H, Deng X, Abe H, Nakasone T, Mori N, Sata T, et al: Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cells. Cancer Sci. 97:1381–1387. 2006. View Article : Google Scholar : PubMed/NCBI